Wexler Wallace is a nationally recognized leader in complex mass tort and medical device litigation. Our firm investigates and aggressively pursues mass tort claims that promote changes intended to benefit the public, prevent future lawsuits and provide the maximum remedies under the law for those who have been harmed. Our lawyers and staff are intimately familiar with the nuances of this complicated practice area and continually track the impact of new technological and scientific developments on mass tort litigation.
To deepen the legal team’s medical knowledge and resources and support those clients who have suffered injuries, Wexler Wallace employs a full-time registered nurse with certification as a Legal Nurse Consultant (LNC). Debbie A. Pritts, RN, LNCC has over twenty-five years of experience and works directly with our clients through virtually every stage of the mass tort legal process.
Mass tort litigation may arise when a manufacturer or retailer makes and/or sells a defective product, including defective drugs or medical devices. These products may, because of their defects, injure hundreds or even thousands of innocent people. Product liability laws can hold manufacturers and retailers responsible for injuries associated with the intended use of a product. In some cases, even when the product was used improperly by the consumer, the manufacturer can be found liable if it could have foreseen the improper use. Persons injured by defective products may be able to assert claims for:
- Strict liability
- Breach of warranty and/or consumer protection
- Manufacturing or design defects
- Failure to adequately warn the consumer of danger
If you would like further information about the firm’s mass tort practice, or if you believe you have been the victim of a mass tort, please contact us.
Mass Tort Litigation cases
Invokana Mass Tort Litigation
In 2013, Johnson & Johnson introduced the diabetes drug Invokana to the market. A little more than two years after Invokana’s introduction to the market, the U.S. Food and Drug Administration issued a warning about serious risks associated with Invokana and other similar SGLT2 inhibitors. Problems associated with Invokana include kidney failure, kidney impairment, kidney stones, urinary tract infections, and abnormal weight loss. Wexler Wallace is currently representing individuals who are or have taken Invokana and experienced complications or side effects from taking the drug. Read more.
In re Testosterone Replacement Therapy Products Liability Litigation
Wexler Wallace LLP represents men who have suffered serious side effects arising from the use of testosterone products. On January 1, 2014, the FDA issued an alert and announced that they were investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products. The FDA was reacting to recent studies that suggested that certain groups of men face a considerable risk of heart attacks if they take testosterone. Testosterone products are approved to treat men who lack testosterone or have low testosterone levels, in conjunction with an associated medical condition. Read more.
View more mass tort cases brought by Wexler Wallace.
Mass Tort Litigation Investigations
Zofran Mass Tort Litigation
Wexler Wallace LLP is actively pursuing cases against GlaxoSmithKline, the manufacturer of the prescription drug Zofran (Ondansetron). Zofran is an anti-nausea medication approved for use by the FDA to treat nausea post-operatively and in patients undergoing cancer therapy. Though never approved for use during pregnancy, Zofran has been extensively promoted and marketed for off-label use to treat women experiencing morning sickness. Due to this off-label promotion, thousands of women have taken Zofran during their first trimester of pregnancy, an extremely significant time of fetal development. Read more.
DePuy ASR™ Hip System Recall Litigation
On August 26, 2010, DePuy Orthopedics, Inc., a division of Johnson & Johnson, announced a worldwide recall of two hip implant systems – the ASR™ XL Acetabular System and the ASR™ Hip Resurfacing System. DePuy has estimated that 93,000 total devices have been implanted worldwide. If they have not already experienced hip failure, patients with these implants may now need to undergo costly and painful revision surgery. Read more.